Eyestem’s Series B Funding Propels Valuation Up by 70%
Eyestem Research raised $10M in Series B, with a valuation of Rs 592 crore, developing eye disease therapies.
Read moreDetailsEyestem Research raised $10M in Series B, with a valuation of Rs 592 crore, developing eye disease therapies.
Read moreDetailsEyestem Research raised $10 million to advance its Phase 2 clinical trial for dry AMD treatments.
Read moreDetails
© 2026 StartupSuperb - Latest Indian Startup News StartupSuperb.
© 2026 StartupSuperb - Latest Indian Startup News StartupSuperb.